Understanding why Duchenne Muscular Dystrophy worsens and how to stop it
Official title: Failure to resolve an adaptive stress state contributes to Duchenne Muscular Dystrophy Severity
Funded at University of Southern California · NIH-11502706 · Data updated 2026-11-12
A research team at USC is studying Duchenne muscular dystrophy to find out why the disease continues to progress and how to interrupt harmful changes in muscle tissue.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project start | September 23, 2026 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $211,650 |
| NIH project number | 1R21AR088867-01 |
| Project ID | NIH-11502706 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants would be adults with Duchenne muscular dystrophy or muscle tissue samples from adults affected by DMD, as appropriate for future translational steps.
✕Less likely to help
Patients without Duchenne or whose tissue samples do not align with the study’s aims may not benefit.
What this research studies
This project looks at why muscles in Duchenne patients fail to recover after damage and how certain cellular stress pathways may cause ongoing muscle decline. Researchers will use imaging and pilot experiments to study changes in muscle-supporting cells when dystrophin is missing. The goal is to identify steps where therapies could prevent or reverse the harmful state that drives disease progression. The work is designed to build a foundation for future interventions that could help people living with Duchenne. The study is limited to early, preliminary experiments over a defined funding period at USC.
Why it matters
Potential benefit: If successful, the work could point to new targets to slow or halt muscle deterioration in Duchenne patients.
How similar studies have gone: Similar work has shown that understanding cellular stress responses can reveal new therapeutic angles, but translating to patients remains a key next step.
Where this research is happening
-
University of Southern California
Los Angeles, United States Active
Researchers
- Principal investigator: Almada, Albert Ernesto — University of Southern California
- Study coordinator: Almada, Albert Ernesto
Related research
Other NIH-funded projects on the same topics.
-
Advancing manufacturing and release testing for a Duchenne gene editing therapy
A project to optimize how a dual-vector AAV gene editing treatment for Duchenne muscular dystrophy is made and tested, so it can move toward clinical use.
-
Stopping steroid-related muscle and bone wasting in Duchenne muscular dystrophy
Researchers are testing ways to protect muscles and bones in people with Duchenne muscular dystrophy who take long-term steroid medicines.
-
MR clues to how nNOS affects energy use and blood flow in Becker and Duchenne muscular dystrophy
This project looks at how advanced MRI tests can track muscle energy and blood flow changes in people with Becker and Duchenne muscular dystrophy as new gene therapies are explored.
-
Digital motor-skill tracking for infants with Duchenne Muscular Dystrophy using wearables
A wearable-sensor project aims to quietly track and quantify how motor skills develop in babies and young boys with Duchenne Muscular Dystrophy.
-
Genetic factors that influence Duchenne Muscular Dystrophy progression
A study to find genes that change how severe Duchenne muscular dystrophy is in boys and young men, using patient data and DNA samples.
-
Optimizing gene therapy to help breathing in Duchenne muscular dystrophy
A Duke University team is testing a gene therapy approach to improve breathing in boys with Duchenne muscular dystrophy.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.